Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 2855       

    Article Cited by others

ORIGINAL ARTICLE

Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020

Murhekar Manoj V, Bhatnagar Tarun, Selvaraju Sriram, Rade Kiran, Saravanakumar V, Vivian Thangaraj Jeromie Wesley, Kumar Muthusamy Santhosh, Shah Naman, Sabarinathan R, Turuk Alka, Anand Parveen Kumar, Asthana Smita, Balachandar Rakesh, Bangar Sampada Dipak, Bansal Avi Kumar, Bhat Jyothi, Chakraborty Debjit, Rangaraju Chethana, Chopra Vishal, Das Dasarathi, Deb Alok Kumar, Devi Kangjam Rekha, Dwivedi Gaurav Raj, Salim Khan S Muhammad, Haq Inaamul, Kumar M Sunil, Laxmaiah Avula, Madhuka, Mahapatra Amarendra, Mitra Anindya, Nirmala A R, Pagdhune Avinash, Qurieshi Mariya Amin, Ramarao Tekumalla, Sahay Seema, Sharma Y K, Shrinivasa Marinaik Basavegowdanadoddi, Shukla Vijay Kumar, Singh Prashant Kumar, Viramgami Ankit, Wilson Vimith Cheruvathoor, Yadav Rajiv, Girish Kumar C P, Luke Hanna Elizabeth, Ranganathan Uma Devi, Babu Subash, Sekar Krithikaa, Yadav Pragya D, Sapkal Gajanan N, Das Aparup, Das Pradeep, Dutta Shanta, Hemalatha Rajkumar, Kumar Ashwani, Narain Kanwar, Narasimhaiah Somashekar, Panda Samiran, Pati Sanghamitra, Patil Shripad, Sarkar Kamalesh, Singh Shalini, Kant Rajni, Tripathy Srikanth, Toteja G S, Babu Giridhara R, Kant Shashi, Muliyil J P, Pandey Ravindra Mohan, Sarkar Swarup, Singh Sujeet K, Zodpey Sanjay, Gangakhedkar Raman R, S. Reddy D C, Bhargava Balram

Year : 2020| Volume: 152| Issue : 1 | Page no: 48-60

   This article has been cited by
 
1 High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
Carolin Elizabeth George,Leeberk Raja Inbaraj,Sindhulina Chandrasingh,L. P. de Witte
Epidemiology and Infection. 2021; 149
[Pubmed]  [Google Scholar] [DOI]
2 COVID-19 case fatality rates can be highly misleading in resource poor and fragile nations: the case of Yemen
Mohammed Noushad,Inas Shakeeb Al Saqqaf
Clinical Microbiology and Infection. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study
Om Prakash,Bhavin Solanki,Jay K Sheth,Bhavin Joshi,Mina Kadam,Sheetal Vyas,Aparajita Shukla,Hemant Tiwari,Sanjay Rathod,Anil Rajput,Toral Trivedi,Vaibhav Ramanuj,Anand Solanki
BMJ Open. 2021; 11(1): e044101
[Pubmed]  [Google Scholar] [DOI]
4 Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)?
Andreas Ruppel,Mohammad Ibrahim Halim,Rhondemo Kikon,Nouh S. Mohamed,Mohammad Reza Saebipour
Global Health Action. 2021; 14(1): 1863129
[Pubmed]  [Google Scholar] [DOI]
5 Descriptive epidemiology of SARS-CoV-2 infection in Karnataka state, South India: Transmission dynamics of symptomatic vs. asymptomatic infections
Narendra Kumar,Shafeeq K. Shahul Hameed,Giridhara R. Babu,Manjunatha M. Venkataswamy,Prameela Dinesh,Prakash Kumar BG,Daisy A. John,Anita Desai,Vasanthapuram Ravi
EClinicalMedicine. 2021; : 100717
[Pubmed]  [Google Scholar] [DOI]
6 Epidemiological profiles and associated risk factors of SARS-CoV-2 positive patients based on a high-throughput testing facility in India
Sumit Malhotra,Manju Rahi,Payal Das,Rini Chaturvedi,Jyoti Chhibber-Goel,Anup Anvikar,Hari Shankar,C. P. Yadav,Jaipal Meena,Shalini Tewari,Sudha V. Gopinath,Reba Chhabra,Amit Sharma
Open Biology. 2021; 11(6): 200288
[Pubmed]  [Google Scholar] [DOI]
7 The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India
Giridhara R. Babu,Rajesh Sundaresan,Siva Athreya,Jawaid Akhtar,Pankaj Kumar Pandey,Parimala S. Maroor,M. Rajagopal Padma,R. Lalitha,Mohammed Shariff,Lalitha Krishnappa,C.N. Manjunath,Mysore Kalappa Sudarshan,Gopalkrishna Gururaj,Timmanahalli Sobagaiah Ranganath,Kumar D.E. Vasanth,Pradeep Banandur,Deepa Ravi,Shilpa Shiju,Eunice Lobo,Asish Satapathy,Lokesh Alahari,Prameela Dinesh,Vinitha Thakar,Anita Desai,Ambica Rangaiah,Ashok Munivenkatappa,Krishna S,Shantala Gowdara Basawarajappa,H.G. Sreedhara,Siddesh KC,Amrutha Kumari B,Nawaz Umar,Mythri BA,Ravi Vasanthapuram
International Journal of Infectious Diseases. 2021; 108: 27
[Pubmed]  [Google Scholar] [DOI]
8 Geographical Appraisal of COVID-19 in West Bengal, India
Biplab Biswas,Rabindranath Roy,Tanusri Roy,Sumanta Chowdhury,Asish Dhara,Kamonasish Mistry
GeoJournal. 2021;
[Pubmed]  [Google Scholar] [DOI]
9 COVID-19: Is herd immunity, the only option for fragile Yemen?
Mohammed Noushad,Inas Shakeeb AbdulWareth Al-Saqqaf
International Journal of Infectious Diseases. 2021;
[Pubmed]  [Google Scholar] [DOI]
10 SARS-CoV-2 re-infection risk in Austria
Stefan Pilz,Ali Chakeri,John PA Loannidis,Lukas Richter,Verena Theiler-Schwetz,Christian Trummer,Robert Krause,Franz Allerberger
European Journal of Clinical Investigation. 2021;
[Pubmed]  [Google Scholar] [DOI]
11 COVID-19 seropositivity among non-medical frontline office staff from two cities in Rajasthan, India
Vidhi Jain,ManojKumar Gupta,Malika Grover,Tejashree Nare,Saumya Srivastava,Pankaj Bhardwaj,AkhilDhanesh Goel,Suman Saurabh,Sanjeeta Dara,Ashok Kumar,Praveen Sharma,VijayaLakshmi Nag,Sanjeev Misra
Journal of Family Medicine and Primary Care. 2021; 10(6): 2400
[Pubmed]  [Google Scholar] [DOI]
12 Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city
Om Prakash,Bhavin Solanki,Jay Sheth,Divyang Oza,Mina Kadam,Sheetal Vyas,Aparajita Shukla,Jayshri Pethani,Hemant Tiwari
Journal of Family Medicine and Primary Care. 2021; 10(6): 2363
[Pubmed]  [Google Scholar] [DOI]
13 Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
Jaya Singh Kshatri,Debdutta Bhattacharya,Srikanta Kanungo,Sidhartha Giri,Subrata Kumar Palo,Debaprasad Parai,Jyotirmayee Turuk,Asit Mansingh,Hari Ram Choudhary,Matrujyoti Pattnaik,Girish Chandra Dash,Prasantajyoti Mohanty,Niranjan Mishra,Durga Madhab Satapathy,Sanjaya Kumar Sahoo,Sanghamitra Pati
Scientific Reports. 2021; 11(1)
[Pubmed]  [Google Scholar] [DOI]
14 Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra
Cristina Royo-Cebrecos,David Vilanova,Joel López,Vanesa Arroyo,Marc Pons,Guillem Francisco,Mireia G. Carrasco,Josep M. Piqué,Sergi Sanz,Carlota Dobaño,Alberto L. García-Basteiro
The Lancet Regional Health - Europe. 2021; : 100119
[Pubmed]  [Google Scholar] [DOI]
15 Seroprevalence of COVID-19 infection in a rural district of South India: A population-based seroepidemiological study
Leeberk Raja Inbaraj,Carolin Elizabeth George,Sindhulina Chandrasingh,Muralidhar M. Kulkarni
PLOS ONE. 2021; 16(3): e0249247
[Pubmed]  [Google Scholar] [DOI]
16 Prediction of COVID-19 cases using the weather integrated deep learning approach for India
Kantha Rao Bhimala,Gopal Krishna Patra,Rajasekhar Mopuri,Srinivasa Rao Mutheneni
Transboundary and Emerging Diseases. 2021;
[Pubmed]  [Google Scholar] [DOI]
17 Critical interpretative synthesis of herd immunity for COVID-19 pandemic
Suneela Garg,MeghachandraM Singh,ChetanaPrakash Deshmukh,Nidhi Bhatnagar,AmodL Borle,Raman Kumar
Journal of Family Medicine and Primary Care. 2021; 10(3): 1117
[Pubmed]  [Google Scholar] [DOI]
18 Evaluating alternative hypotheses to explain the downward trend in the indices of the COVID-19 pandemic death rate
Sonali Shinde,Pratima Ranade,Milind Watve
PeerJ. 2021; 9: e11150
[Pubmed]  [Google Scholar] [DOI]
19 Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study
Adriano Antunes de Souza Araújo,Lucindo José Quintans-Júnior,Luana Heimfarth,Dulce Marta Schimieguel,Cristiane Bani Corrêa,Tatiana Rodrigues de Moura,Rafael Ciro Marques Cavalcante,Rangel Rodrigues Bomfim,Renata Grespan,Lorranny Santana Rodrigues,Danillo Menezes dos Santos,Ayane de Sá Resende,Nathanielly de Lima Silva,Anna Clara Ramos da Silva Santos,Jéssica Maria Dantas Araújo,Mércia Feitosa de Souza,Marco Aurélio de Oliveira Góes,Victor Santana Santos,Paulo Ricardo Martins-Filho
Epidemiology and Infection. 2021; 149
[Pubmed]  [Google Scholar] [DOI]
20 Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen,Zhiyuan Chen,Andrew S Azman,Xiaowei Deng,Ruijia Sun,Zeyao Zhao,Nan Zheng,Xinghui Chen,Wanying Lu,Tingyu Zhuang,Juan Yang,Cecile Viboud,Marco Ajelli,Daniel T Leung,Hongjie Yu
The Lancet Global Health. 2021;
[Pubmed]  [Google Scholar] [DOI]
21 The COVID-19 vaccine: A race nearing the finish line
TarunKumar Suvvari,Siddhi Hegde,Shreya Sreeram,LV Simhachalam Kutikuppala
Apollo Medicine. 2021; 0(0): 0
[Pubmed]  [Google Scholar] [DOI]
22 Tracking SARS-CoV-2 infection in India with serology
Jacob John,Gagandeep Kang
The Lancet Global Health. 2021;
[Pubmed]  [Google Scholar] [DOI]
23 Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned
Mario Poljak,Anja Oštrbenk Valencak,Erik Štrumbelj,Polona Maver Vodicar,Vasja Vehovar,Katarina Resman Rus,Miša Korva,Nataša Knap,Katja Seme,Miroslav Petrovec,Blaž Zupan,Janez Demšar,Slavko Kurdija,Tatjana Avšic Županc
Clinical Microbiology and Infection. 2021;
[Pubmed]  [Google Scholar] [DOI]
24 Seroprevalence of SARS-CoV-2 specific IgG antibodies among eye care workers in South India
Rajapandian Siva Ganesa Karthikeyan,Gunasekaran Rameshkumar,Chidambaranathan Gowri Priya,Prajna Lalitha,Ramamoorthi Devi,Mani Iswarya,Ravilla D. Ravindran
Indian Journal of Medical Microbiology. 2021;
[Pubmed]  [Google Scholar] [DOI]
25 Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study
Mioljub Ristic,Biljana Milosavljevic,Slobodanka Vapa,Miloš Markovic,Vladimir Petrovic,Martin Chtolongo Simuunza
PLOS ONE. 2021; 16(7): e0254516
[Pubmed]  [Google Scholar] [DOI]
26 Retrospective of International Serological Studies on the Formation and Dynamics of the Humoral Immune Response to SARS-CoV-2: from 2020 to 2021
E. A. Novikova,A. G. Petrova,E. V. Moskaleva,A. S. Vanyarkin?,L. V. Rychkova
Acta Biomedica Scientifica. 2021; 6(2): 47
[Pubmed]  [Google Scholar] [DOI]
27 Beyond the numbers: understanding the diversity of covid-19 epidemiology and response in South Asia
Zulfiqar A Bhutta,Sameen Siddiqi,Assad Hafeez,Muhammad Islam,Samiran Nundy,Firdausi Qadri,Faisal Sultan
BMJ. 2021; : n1544
[Pubmed]  [Google Scholar] [DOI]
28 SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study
Antoine Lewin,Roseline Therrien,Gaston De Serres,Yves Grégoire,Josée Perreault,Mathieu Drouin,Marie-Josée Fournier,Tony Tremblay,Julie Beaudoin,Guillaume Beaudoin-Bussières,Jérémie Prévost,Gabrielle Gendron-Lepage,Andrés Finzi,France Bernier,Renée Bazin,Marc Germain,Gilles Delage
Canadian Journal of Public Health. 2021;
[Pubmed]  [Google Scholar] [DOI]
29 The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study
Selma Regina Penha Silva Cerqueira,Patrícia Duarte Deps,Débora Vilela Cunha,Natanael Victor Furtunato Bezerra,Daniel Holanda Barroso,Ana Bárbara Sapienza Pinheiro,Gecilmara Salviato Pillegi,Taynah Alves Rocha Repsold,Patrícia Shu Kurizky,Simon M. Collin,Ciro Martins Gomes,Vinicius M. Fava
PLOS Neglected Tropical Diseases. 2021; 15(7): e0009635
[Pubmed]  [Google Scholar] [DOI]
30 The association of ABO blood group with the asymptomatic COVID-19 cases in India
Prajjval Pratap Singh,Abhishek K. Srivastava,Sudhir K. Upadhyay,Ashish Singh,Shashank Upadhyay,Pradeep Kumar,Vandana Rai,Pankaj Shrivastava,Gyaneshwer Chaubey
Transfusion and Apheresis Science. 2021; : 103224
[Pubmed]  [Google Scholar] [DOI]
31 Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India
Sriram Selvaraju,Muthusamy Santhosh Kumar,Jeromie Wesley Vivian Thangaraj,Tarun Bhatnagar,Velusamy Saravanakumar,Chethrapilly Purushothaman Girish Kumar,Krithikaa Sekar,Ezhilarasan Ilayaperumal,Ramasamy Sabarinathan,Murugesan Jagadeesan,Masanam Sriramulu Hemalatha,Manoj Vasant Murhekar
Emerging Infectious Diseases. 2021; 27(2): 586
[Pubmed]  [Google Scholar] [DOI]
32 Letter to the Editor on “Visitation restrictions: is it right and how do we support families in the NICU during COVID 19?”
D. V. Venkatesh Murthy,N. Karthik Nagesh
Journal of Perinatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
33 Optimizing testing for COVID-19 in India
Philip Cherian,Sandeep Krishna,Gautam I. Menon,Benjamin Muir Althouse
PLOS Computational Biology. 2021; 17(7): e1009126
[Pubmed]  [Google Scholar] [DOI]
34 Estimating the proportion and IgG antibody response to SARS-CoV-2 in individuals joining a central educational institute from different parts of India by Enzyme-linked immunosorbent assay (ELISA) based serology
Sourav Sen,Mahima Lall,Dharamjeet Singh Faujdar,S.P.S. Shergill,Seema Patrikar,S.K. Kaushik,R.M. Gupta,Nardeep Naithani
Medical Journal Armed Forces India. 2021; 77: S366
[Pubmed]  [Google Scholar] [DOI]
35 Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys
Jaya Singh Kshatri,Debdutta Bhattacharya,Ira Praharaj,Asit Mansingh,Debaprasad Parai,Srikanta Kanungo,Subrata Kumar Palo,Sidhartha Giri,Matrujyoti Pattnaik,Shakti Ranjan Barik,Girish Chandra Dash,Hari Ram Choudhary,Jyotirmayee Turuk,Nitya Nanda Mandal,Sanghamitra Pati
Epidemiology and Infection. 2021; 149
[Pubmed]  [Google Scholar] [DOI]
36 SARS-CoV2 IgG antibody: Seroprevalence among health care workers
Om Prakash,Bhavin Solanki,Jay Sheth,Govind Makwana,Mina Kadam,Sheetal Vyas,Aparajita Shukla,Jayshri Pethani,Hemant Tiwari
Clinical Epidemiology and Global Health. 2021; : 100766
[Pubmed]  [Google Scholar] [DOI]
37 Precision shielding for COVID-19: metrics of assessment and feasibility of deployment
John P A Ioannidis
BMJ Global Health. 2021; 6(1): e004614
[Pubmed]  [Google Scholar] [DOI]
38 Incorporating false negative tests in epidemiological models for SARS-CoV-2 transmission and reconciling with seroprevalence estimates
Rupam Bhattacharyya,Ritoban Kundu,Ritwik Bhaduri,Debashree Ray,Lauren J. Beesley,Maxwell Salvatore,Bhramar Mukherjee
Scientific Reports. 2021; 11(1)
[Pubmed]  [Google Scholar] [DOI]
39 Modelling and analysis of COVID-19 epidemic in India
Alok Tiwari
Journal of Safety Science and Resilience. 2020;
[Pubmed]  [Google Scholar] [DOI]
40 SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy)
Vieri Lastrucci,Chiara Lorini,Marco Del Riccio,Eleonora Gori,Fabrizio Chiesi,Gino Sartor,Beatrice Zanella,Sara Boccalini,Angela Bechini,Francesco Puggelli,Paolo Bonanni,Guglielmo Bonaccorsi
Vaccines. 2020; 8(4): 778
[Pubmed]  [Google Scholar] [DOI]
41 SARS-CoV-2 Seroprevalence Study in Pimpri-Chinchwad, Maharashtra, India Coinciding with Falling Trend – Do the Results Suggest Imminent Herd Immunity?
Amitav Banerjee,Bhargav Gaikwad,Atul Desale,Sudhir L. Jadhav,Jitendra Bhawalkar,Pavan Salve,Varsha Dange,Chandrashekhar Raut
SSRN Electronic Journal. 2020;
[Pubmed]  [Google Scholar] [DOI]
42 The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature
Bruna Aparecida Souza Machado,Katharine Valéria Saraiva Hodel,Valdir Gomes Barbosa-Júnior,Milena Botelho Pereira Soares,Roberto Badaró
Viruses. 2020; 13(1): 40
[Pubmed]  [Google Scholar] [DOI]
43 COVID Convalescence- A boon or bane in cardiac surgery?..: A “second hit” hypothesis.
Srinath Damodaran,Shreedhar S. Joshi,Sunil Kumar,Pooja Natarajan,Sanjay Orathi Patangi,Thiruthani Kumaran
Journal of Cardiothoracic and Vascular Anesthesia. 2020;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article